Schedule 13G ownership disclosure

ELECTRA THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 284825106

Event date: 2026-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Westlake BioPartners Fund I, L.P.

    Shares: 3,527,136.00 · Class: 5.6%

  • Westlake BioPartners GP I, LLC

    Shares: 3,527,136.00 · Class: 5.6%

  • Westlake BioPartners Fund II, L.P.

    Shares: 2,820,403.00 · Class: 4.5%

  • Westlake BioPartners GP II, LLC

    Shares: 2,820,403.00 · Class: 4.5%

  • Dr. Beth C. Seidenberg

    Shares: 6,347,539.00 · Class: 10.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-120294
Form type
SCHEDULE 13G
Filer
Electra Therapeutics, Inc.
CIK
CIK 2088082
Filed
Oct 29, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub